CN1539459A - 一种治疗贫血的再造生血中药制剂及制备方法 - Google Patents
一种治疗贫血的再造生血中药制剂及制备方法 Download PDFInfo
- Publication number
- CN1539459A CN1539459A CNA2003101032158A CN200310103215A CN1539459A CN 1539459 A CN1539459 A CN 1539459A CN A2003101032158 A CNA2003101032158 A CN A2003101032158A CN 200310103215 A CN200310103215 A CN 200310103215A CN 1539459 A CN1539459 A CN 1539459A
- Authority
- CN
- China
- Prior art keywords
- radix
- preparation
- herba
- chinese medicine
- hemopoietic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims description 69
- 238000002360 preparation method Methods 0.000 title claims description 64
- 208000007502 anemia Diseases 0.000 title claims description 34
- 210000004369 blood Anatomy 0.000 title description 9
- 239000008280 blood Substances 0.000 title description 9
- 239000002398 materia medica Substances 0.000 title 1
- 239000003814 drug Substances 0.000 claims abstract description 39
- 239000000843 powder Substances 0.000 claims abstract description 32
- 239000006187 pill Substances 0.000 claims abstract description 10
- 239000002775 capsule Substances 0.000 claims abstract description 8
- 230000002607 hemopoietic effect Effects 0.000 claims description 29
- 239000007788 liquid Substances 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 230000008569 process Effects 0.000 claims description 18
- 239000009636 Huang Qi Substances 0.000 claims description 17
- 108010052008 colla corii asini Proteins 0.000 claims description 17
- 241000756943 Codonopsis Species 0.000 claims description 16
- 238000001035 drying Methods 0.000 claims description 16
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 16
- 210000000582 semen Anatomy 0.000 claims description 16
- 239000008187 granular material Substances 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 15
- 241000208340 Araliaceae Species 0.000 claims description 10
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 10
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 10
- 235000008434 ginseng Nutrition 0.000 claims description 10
- 239000002671 adjuvant Substances 0.000 claims description 9
- 235000008504 concentrate Nutrition 0.000 claims description 9
- 239000012141 concentrate Substances 0.000 claims description 9
- 239000000706 filtrate Substances 0.000 claims description 9
- 238000010438 heat treatment Methods 0.000 claims description 9
- 235000020357 syrup Nutrition 0.000 claims description 9
- 239000006188 syrup Substances 0.000 claims description 9
- 239000012153 distilled water Substances 0.000 claims description 7
- 150000003839 salts Chemical class 0.000 claims description 7
- 229920001353 Dextrin Polymers 0.000 claims description 6
- 239000004375 Dextrin Substances 0.000 claims description 6
- 229920002472 Starch Polymers 0.000 claims description 6
- 235000019425 dextrin Nutrition 0.000 claims description 6
- 239000012467 final product Substances 0.000 claims description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 6
- 239000008107 starch Substances 0.000 claims description 6
- 235000019698 starch Nutrition 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 3
- 230000002421 anti-septic effect Effects 0.000 claims description 3
- -1 drying Substances 0.000 claims description 3
- 235000019359 magnesium stearate Nutrition 0.000 claims description 3
- 150000002772 monosaccharides Chemical class 0.000 claims description 3
- 235000020374 simple syrup Nutrition 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 13
- 208000032467 Aplastic anaemia Diseases 0.000 abstract description 7
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 abstract description 4
- 201000002364 leukopenia Diseases 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 abstract 1
- 108010010803 Gelatin Proteins 0.000 abstract 1
- 240000007890 Leonurus cardiaca Species 0.000 abstract 1
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 229920000159 gelatin Polymers 0.000 abstract 1
- 239000008273 gelatin Substances 0.000 abstract 1
- 235000019322 gelatine Nutrition 0.000 abstract 1
- 235000011852 gelatine desserts Nutrition 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 description 19
- 241000699670 Mus sp. Species 0.000 description 14
- 238000012360 testing method Methods 0.000 description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 229940079593 drug Drugs 0.000 description 9
- 210000003734 kidney Anatomy 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 8
- 230000002093 peripheral effect Effects 0.000 description 8
- 241000700159 Rattus Species 0.000 description 7
- 230000037396 body weight Effects 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 210000000265 leukocyte Anatomy 0.000 description 6
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 5
- 239000013642 negative control Substances 0.000 description 5
- 108020004707 nucleic acids Proteins 0.000 description 5
- 102000039446 nucleic acids Human genes 0.000 description 5
- 150000007523 nucleic acids Chemical class 0.000 description 5
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 210000001185 bone marrow Anatomy 0.000 description 4
- 229960004397 cyclophosphamide Drugs 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 238000001802 infusion Methods 0.000 description 4
- 208000030760 Anaemia of chronic disease Diseases 0.000 description 3
- 206010065553 Bone marrow failure Diseases 0.000 description 3
- 208000022400 anemia due to chronic disease Diseases 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000002512 chemotherapy Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 208000007475 hemolytic anemia Diseases 0.000 description 3
- 231100001022 leukopenia Toxicity 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000003285 pharmacodynamic effect Effects 0.000 description 3
- 238000001243 protein synthesis Methods 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 230000014616 translation Effects 0.000 description 3
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- 102000015696 Interleukins Human genes 0.000 description 2
- 108010063738 Interleukins Proteins 0.000 description 2
- 231100000111 LD50 Toxicity 0.000 description 2
- 241001529936 Murinae Species 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- RJURFGZVJUQBHK-UHFFFAOYSA-N actinomycin D Natural products CC1OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C(=O)C(C(C)C)NC(=O)C1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)NC4C(=O)NC(C(N5CCCC5C(=O)N(C)CC(=O)N(C)C(C(C)C)C(=O)OC4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-UHFFFAOYSA-N 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000002798 bone marrow cell Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 231100001252 long-term toxicity Toxicity 0.000 description 2
- 238000001668 nucleic acid synthesis Methods 0.000 description 2
- 230000022558 protein metabolic process Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 235000019786 weight gain Nutrition 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 108010092160 Dactinomycin Proteins 0.000 description 1
- 206010011953 Decreased activity Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- HLFSDGLLUJUHTE-SNVBAGLBSA-N Levamisole Chemical compound C1([C@H]2CN3CCSC3=N2)=CC=CC=C1 HLFSDGLLUJUHTE-SNVBAGLBSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- LKAJKIOFIWVMDJ-IYRCEVNGSA-N Stanazolol Chemical compound C([C@@H]1CC[C@H]2[C@@H]3CC[C@@]([C@]3(CC[C@@H]2[C@@]1(C)C1)C)(O)C)C2=C1C=NN2 LKAJKIOFIWVMDJ-IYRCEVNGSA-N 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- RJURFGZVJUQBHK-IIXSONLDSA-N actinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-IIXSONLDSA-N 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 229960000640 dactinomycin Drugs 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000004992 fission Effects 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000003760 hair shine Effects 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000003118 histopathologic effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 238000009592 kidney function test Methods 0.000 description 1
- 229960001614 levamisole Drugs 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 238000011889 obduction Methods 0.000 description 1
- 238000003305 oral gavage Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 229940011964 pentobarbital sodium 30 mg Drugs 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229960000912 stanozolol Drugs 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 231100000456 subacute toxicity Toxicity 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 206010043554 thrombocytopenia Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200310103215 CN1233390C (zh) | 2003-10-30 | 2003-10-30 | 一种治疗贫血的再造生血中药制剂及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200310103215 CN1233390C (zh) | 2003-10-30 | 2003-10-30 | 一种治疗贫血的再造生血中药制剂及制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1539459A true CN1539459A (zh) | 2004-10-27 |
CN1233390C CN1233390C (zh) | 2005-12-28 |
Family
ID=34333243
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200310103215 Expired - Lifetime CN1233390C (zh) | 2003-10-30 | 2003-10-30 | 一种治疗贫血的再造生血中药制剂及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1233390C (zh) |
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100998857B (zh) * | 2007-01-22 | 2010-10-06 | 秦玉东 | 一种补肾补血保健茶及其制备方法 |
CN101361858B (zh) * | 2008-09-28 | 2011-04-06 | 袁六妮 | 一种治疗再生障碍性贫血药物 |
CN101596255B (zh) * | 2009-06-26 | 2011-06-15 | 曹志强 | 一种用于治疗再生障碍性贫血的中药制剂 |
CN102178839A (zh) * | 2011-04-20 | 2011-09-14 | 长春中医药大学 | 一种治疗血虚证的药物组合物及其制备方法 |
CN102266476A (zh) * | 2010-06-07 | 2011-12-07 | 郝艳涛 | 一种益肝明目、滋阴补肾的药物组合 |
CN101254275B (zh) * | 2008-03-10 | 2012-01-11 | 屈凤星 | 一种治疗再生障碍性贫血的中药 |
CN102356876A (zh) * | 2011-10-09 | 2012-02-22 | 王姗思 | 一种防治女性早衰的保健食品及其制备方法 |
CN102366450A (zh) * | 2011-10-20 | 2012-03-07 | 朱建华 | 龙鹿再生汤及其用途 |
CN102441126A (zh) * | 2011-12-07 | 2012-05-09 | 葛晓云 | 一种补血、滋阴的中药药酒 |
CN102579598A (zh) * | 2011-01-06 | 2012-07-18 | 北京宝德润生医药科技发展有限公司 | 一种用于改善营养性贫血的组合物及其制备方法 |
CN102698080A (zh) * | 2012-06-19 | 2012-10-03 | 黄芸 | 治疗老年性贫血补骨脂中药口服液及制备方法 |
CN102727806A (zh) * | 2012-05-31 | 2012-10-17 | 刘敏 | 一种补气治疗再生障碍性贫血的中药 |
CN102813814A (zh) * | 2012-07-21 | 2012-12-12 | 刘先仕 | 治疗低血压的中药方剂 |
CN103191304A (zh) * | 2013-04-10 | 2013-07-10 | 郑世花 | 一种治疗血瘀型再生障碍性贫血的中药组合物 |
CN103330832A (zh) * | 2013-05-29 | 2013-10-02 | 陈松 | 一种治疗贫血的中药 |
CN103385975A (zh) * | 2013-07-01 | 2013-11-13 | 冯子政 | 治疗血小板低下的中药药物 |
CN103505679A (zh) * | 2013-08-30 | 2014-01-15 | 杜丽娟 | 一种治疗血液病的药物和制备方法及其应用 |
CN103751607A (zh) * | 2014-01-11 | 2014-04-30 | 姜丽莎 | 一种治疗再生障碍性贫血的中药组合物 |
CN103877486A (zh) * | 2014-04-09 | 2014-06-25 | 刘洁 | 用于促升放化疗后白细胞数量的药物及其制备方法 |
CN104147349A (zh) * | 2014-08-18 | 2014-11-19 | 马永波 | 一种治疗再生障碍性贫血的中药组合物 |
CN104857403A (zh) * | 2015-06-04 | 2015-08-26 | 刘和花 | 治疗贫血的中药组合物及其制备方法 |
-
2003
- 2003-10-30 CN CN 200310103215 patent/CN1233390C/zh not_active Expired - Lifetime
Cited By (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100998857B (zh) * | 2007-01-22 | 2010-10-06 | 秦玉东 | 一种补肾补血保健茶及其制备方法 |
CN101254275B (zh) * | 2008-03-10 | 2012-01-11 | 屈凤星 | 一种治疗再生障碍性贫血的中药 |
CN101361858B (zh) * | 2008-09-28 | 2011-04-06 | 袁六妮 | 一种治疗再生障碍性贫血药物 |
CN101596255B (zh) * | 2009-06-26 | 2011-06-15 | 曹志强 | 一种用于治疗再生障碍性贫血的中药制剂 |
CN102266476A (zh) * | 2010-06-07 | 2011-12-07 | 郝艳涛 | 一种益肝明目、滋阴补肾的药物组合 |
CN102579598A (zh) * | 2011-01-06 | 2012-07-18 | 北京宝德润生医药科技发展有限公司 | 一种用于改善营养性贫血的组合物及其制备方法 |
CN102178839B (zh) * | 2011-04-20 | 2012-05-23 | 长春中医药大学 | 一种治疗血虚证的药物组合物及其制备方法 |
CN102178839A (zh) * | 2011-04-20 | 2011-09-14 | 长春中医药大学 | 一种治疗血虚证的药物组合物及其制备方法 |
CN102356876A (zh) * | 2011-10-09 | 2012-02-22 | 王姗思 | 一种防治女性早衰的保健食品及其制备方法 |
CN102366450B (zh) * | 2011-10-20 | 2013-03-20 | 朱建华 | 龙鹿再生汤及其用途 |
CN102366450A (zh) * | 2011-10-20 | 2012-03-07 | 朱建华 | 龙鹿再生汤及其用途 |
CN102441126B (zh) * | 2011-12-07 | 2013-07-10 | 赵戎 | 一种补血、滋阴的中药药酒 |
CN102441126A (zh) * | 2011-12-07 | 2012-05-09 | 葛晓云 | 一种补血、滋阴的中药药酒 |
CN102727806A (zh) * | 2012-05-31 | 2012-10-17 | 刘敏 | 一种补气治疗再生障碍性贫血的中药 |
CN102698080A (zh) * | 2012-06-19 | 2012-10-03 | 黄芸 | 治疗老年性贫血补骨脂中药口服液及制备方法 |
CN102698080B (zh) * | 2012-06-19 | 2014-01-08 | 黄芸 | 治疗老年性贫血补骨脂中药口服液及制备方法 |
CN102813814B (zh) * | 2012-07-21 | 2013-10-16 | 刘先仕 | 治疗低血压的中药组合物 |
CN102813814A (zh) * | 2012-07-21 | 2012-12-12 | 刘先仕 | 治疗低血压的中药方剂 |
CN103191304A (zh) * | 2013-04-10 | 2013-07-10 | 郑世花 | 一种治疗血瘀型再生障碍性贫血的中药组合物 |
CN103330832A (zh) * | 2013-05-29 | 2013-10-02 | 陈松 | 一种治疗贫血的中药 |
CN103385975A (zh) * | 2013-07-01 | 2013-11-13 | 冯子政 | 治疗血小板低下的中药药物 |
CN103505679A (zh) * | 2013-08-30 | 2014-01-15 | 杜丽娟 | 一种治疗血液病的药物和制备方法及其应用 |
CN103505679B (zh) * | 2013-08-30 | 2015-05-20 | 杜丽娟 | 一种治疗血液病的药物和制备方法及其应用 |
CN103751607A (zh) * | 2014-01-11 | 2014-04-30 | 姜丽莎 | 一种治疗再生障碍性贫血的中药组合物 |
CN103877486A (zh) * | 2014-04-09 | 2014-06-25 | 刘洁 | 用于促升放化疗后白细胞数量的药物及其制备方法 |
CN103877486B (zh) * | 2014-04-09 | 2016-06-01 | 青岛市肿瘤医院 | 用于促升放化疗后白细胞数量的药物及其制备方法 |
CN104147349A (zh) * | 2014-08-18 | 2014-11-19 | 马永波 | 一种治疗再生障碍性贫血的中药组合物 |
CN104857403A (zh) * | 2015-06-04 | 2015-08-26 | 刘和花 | 治疗贫血的中药组合物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1233390C (zh) | 2005-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1233390C (zh) | 一种治疗贫血的再造生血中药制剂及制备方法 | |
CN1306848A (zh) | 防治白细胞减少症的中药制剂及制备工艺 | |
CN101332256B (zh) | 用于鸡传染性法氏囊炎的中药组合物及制备方法 | |
CN102048902B (zh) | 一种治疗肝炎的中药组合物、提取物及制备方法、应用和剂型 | |
CN1927331A (zh) | 一种治疗慢性心力衰竭的中药制剂 | |
CN102302608A (zh) | 一种治疗贫血的中药组合物及其制备方法 | |
CN1539458A (zh) | 一种抗癌参芪扶正中药制剂及制备方法 | |
CN103169880A (zh) | 一种治疗骨髓增生异常综合征的中药组合物及其制备方法 | |
CN103027906B (zh) | 牛蒡子苷元在治疗贫血疾病中的应用 | |
CN1682780A (zh) | 一种治疗尿毒症及肾阳虚、肾衰竭的药物及其制备方法 | |
CN100394969C (zh) | 一种治疗骨质疏松症的中药复方制剂及其制备方法 | |
CN102178839A (zh) | 一种治疗血虚证的药物组合物及其制备方法 | |
CN100352471C (zh) | 治疗继发性贫血、缺铁性贫血的药物及其制备方法 | |
CN1679693A (zh) | 一种治疗肝病的药物及其制备方法 | |
CN104688723A (zh) | 淫羊藿苷元在制备治疗贫血药物中的应用 | |
CN1136939A (zh) | 一种能治愈乙型肝炎的中药制剂及其配制技术 | |
CN1733207A (zh) | 一种用于治疗原发性低血压病的药物组合物 | |
CN110123871B (zh) | 一种提升白细胞及排毒作用的中药组合物制剂及制备方法 | |
CN1233416C (zh) | 一种治疗小儿消化不良的复方胃蛋白酶散剂及其制备方法 | |
CN103127391B (zh) | 一种用于治疗血液病的药物及其制备方法 | |
CN1421238A (zh) | 一种具有抗肿瘤、抗自由基损伤和调节免疫的天然生物反应调节剂 | |
CN1850265A (zh) | 一种治疗肾阳虚证的中药及制备方法 | |
CN1204916C (zh) | 一种治疗抑郁症的药物及其制备方法 | |
CN1166379C (zh) | 治疗肾病的药物及其制备方法 | |
CN1209158C (zh) | 一种治疗小儿病毒性肺炎的清肺口服液制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PP01 | Preservation of patent right |
Effective date of registration: 20070618 Pledge (preservation): Preservation |
|
PD01 | Discharge of preservation of patent |
Date of cancellation: 20080618 Pledge (preservation): Preservation registration |
|
ASS | Succession or assignment of patent right |
Owner name: LIAOYUAN YULONGYA PHARMACEUTICAL CO.LTD. Free format text: FORMER OWNER: LIAOYUAN YADONG MEDICINE CO., LTD., JILIN PROVINCE Effective date: 20080926 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20080926 Address after: Jilin city of Liaoyuan province Yiyang Friendship Road No. 5 Patentee after: LIAOYUAN YULONGYADONG PHARMACEUTICAL Co.,Ltd. Address before: No. 33 Youyi Road, Jilin, Liaoyuan Patentee before: Jilin Liaoyuan Yadong Pharmaceutical Co.,Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20190805 Address after: 236800 Baihe Road 1177, Bozhou Economic Development Zone, Anhui Province Patentee after: Anhui Yulong Yadong Pharmaceutical Co.,Ltd. Address before: 136200 No. 5 Youyiyang Road, Liaoyuan City, Jilin Province Patentee before: LIAOYUAN YULONGYADONG PHARMACEUTICAL Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
CP01 | Change in the name or title of a patent holder |
Address after: 236800 no.1177 Baihe Road, Bozhou Economic Development Zone, Anhui Province Patentee after: Anhui leiyunshang Pharmaceutical Co.,Ltd. Address before: 236800 no.1177 Baihe Road, Bozhou Economic Development Zone, Anhui Province Patentee before: Anhui Yulong Yadong Pharmaceutical Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CX01 | Expiry of patent term |
Granted publication date: 20051228 |
|
CX01 | Expiry of patent term |